LEADER 01449nam  2200361z- 450 
001 9910689420003321
005 20161209100930.0
035   $a(CKB)5860000000022434
035   $a(BIP)007967340
035   $a(EXLCZ)995860000000022434
100   $a20220406c2001uuuu  -u-         -
101 0 $aeng
200 10$aEvaluating the effectiveness of the Food And Drug Administration Modernization Act $ehearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Seventh Congress, first session, May 3, 2001
215   $a1 online resource (iii, 166 p.) 
311   $a0-16-066356-3 
517   $aEvaluating the effectiveness of the Food And Drug Administration Modernization Act 
606   $aPharmaceutical policy$zUnited States
606   $aDrugs$zUnited States$xTesting
606   $aPediatric pharmacology$zUnited States
610   $aUnited States
610   $aPharmaceutical policy
610   $aDrugs
610   $aPediatric pharmacology
610   $aPolitical science
610   $aMedical
615  0$aPharmaceutical policy
615  0$aDrugs$xTesting.
615  0$aPediatric pharmacology
712 02$aU. S. Congress House Committee on Energy and Commerce Subcommittee on Health Staff,$4oth
906   $aBOOK
912   $a9910689420003321
996   $aEvaluating the effectiveness of the Food And Drug Administration Modernization Act$93146684
997   $aUNINA